12% of Global Cancers Linked to Infections, Study Finds

Key points

• IARC study published in The Lancet Oncology links 12% of 2024 cancer cases to 12 infectious agents.
• Helicobacter pylori and HPV are the leading causes, each accounting for about 4% of new diagnoses.
• Hepatitis B and C, along with Epstein-Barr virus, contribute significantly to liver and other cancers.
• Prevention tools like vaccines and antibiotics exist but face uneven global uptake.
• Low- and middle-income countries bear 77% of infection-attributable cancer diagnoses.

Background

This story builds on earlier coverage from late September 2026, which first reported the IARC findings. The new analysis expands on the specific pathogens and prevention strategies, highlighting persistent gaps in vaccination and screening infrastructure globally.

How outlets are covering it

The Independent and The Washington Post focus on the preventable nature of these cancers, emphasizing existing tools like vaccines. Time Magazine provides a deeper dive into the biological mechanisms, such as how EBV hides in immune cells. Clarin.com offers detailed statistics on regional disparities, noting that Eastern Asia accounts for 42% of global infection-attributable cancers. All outlets agree on the 12% figure but differ in emphasis: The Independent highlights everyday risks like tattoos, while Time and Clarin focus on clinical and epidemiological data.

Why it matters

Understanding the link between infections and cancer underscores the importance of vaccination and preventive healthcare. Addressing these gaps could significantly reduce the global cancer burden, particularly in low- and middle-income countries where access to treatments is limited.

What to watch

Researchers hope the new findings will stimulate development of vaccines for pathogens like EBV, which currently lack effective prevention methods. Public health officials are expected to push for improved vaccination rates and screening programs in high-risk regions.